Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lacticaseibacillus casei and Improved Treatment Compliance

Doses used in studies

CFU/day: 6.5 billion (median 6.5 billion, IQR 6.5 billion–6.5 billion) — 1 study

Time to effect

Median: 7 weeks · IQR 7 weeks–7 weeks · Range 7 weeks–7 weeks — Reported in 1 of 1 study

1 of 1 paper

A randomized controlled trial of probiotics to reduce the severity of oral mucositis in patients with oropharyngeal carcinoma undergoing concurrent chemoradiotherapy.
- 2026-01
- RCT · n = 70
- Journal of cancer research and therapeutics 22(1)
- - Saloni Sojitra
  - Tej Prakash Soni
  - Nidhi Patni
  - Dinesh Kumar Singh
  - Naresh Jakhotia
  - Sheh Rawat
  - Anil Kumar Gupta
  - Tara Chand Gupta
  - Naresh Ledwani
  - Harish Singhal
  - Shantanu Sharma
  - Ravindra Singh Gothwal
- PubMed: 41910295
- DOI: 10.4103/jcrt.jcrt_1070_25
4 Insights on
- Improved Treatment Compliance
- High evidence
- Clinical
Compliance was not statistically different in both the arms.
Effect
Neutral
Effect size
Small
Significant
No
Dose
6.5 billion CFU/day (65 ml Yakult)